SWOG clinical trial number
SWOG-7922

Combination Chemotherapy with Cyclophosphamide, Adriamycin, and Cis-Platinum vs. m-AMSA in Patients with Advanced Transitional Cell Cancer of the Urinary Bladder with Good Renal Function

Closed
Phase
Published
Abbreviated Title
Combination Chemotherapy with Cyclophosphamide, Adriamycin, and Cis-Platinum vs. m-AMSA in Patients with Advanced Transitional Cell Cancer of the Urinary Bladder with Good Renal Function
Activated
08/08/1979
Closed
09/10/1982

Publication Information Expand/Collapse

1985

Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: A Southwest Oncology Group study.

M Al-Sarraf;J Frank;JA Smith Jr.;RM O'Bryan;JJ Costanzi;RL Stephens;J Caraveo;ED Crawford Cancer Treat Rep 69:189-194

1983

Combination of Cytoxan, Adriamycin and Cis-platinum (CAP) vs. Phase II agent m-AMSA in patients with advanced and metastatic bladder cancer--A Southwest Oncology Group study.

M Al-Sarraf AACR #558

1982

Combination of Cyclophosphamide, Adriamycin, and Cis- Platinum (CAP) versus m-AMSA in patients with advanced transitional bladder cancer.

M Al-Sarraf ASCO #C-406